BioCentury
ARTICLE | Politics & Policy

House committee passes patent bill with IPR reforms

June 12, 2015 1:06 AM UTC

The U.S. House Judiciary Committee passed the Innovation Act (H.R. 9) Thursday by a 24-8 vote.

The legislation included a provision that would prevent parties, such as hedge funds, from using the inter partes review (IPR) system to manipulate financial markets. Hedge fund manager Kyle Bass has used the IPR system to file challenges against biopharma companies' patents. ...